Search results for abx831575

Veltuzumab, Abbexa, abx831575

Veltuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD20 receptors, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.